The Patent Finder

Dot Therapeutics-1, Inc.

Also on record
Records under this name other than patents Dot Therapeutics-1, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Dot Therapeutics-1, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,802,657Compounds Useful as Raf Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,556,177Substituted 1,3-Thiazoles as Synthetic Intermediates for Preparation of Raf Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,920,048Substituted Pyrimidines for Inhibiting Raf Kinase Activity
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,293,752Compounds Useful as Raf Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,426,782Pharmaceutical Formulations of a Pan-Raf Kinase Inhibitor and Processes for Their Preparation
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,988,469Method for Producing Optically Active Compound
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,129,249Method for Producing Optically Active Compound
Formerly held
In force
 · Medium confidence
In forceMedium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited